This study aimed to further evaluate the effect of the PVR/PVRL2-TIGIT in NB and analyse the combinatory effect of GD2-CAR NK-92 with CRISPR-based TIGIT knockout in NB treatment. Here, TIGIT is linked to neuroblastoma.